Compounds > sibutramine
Page last updated: 2024-08-16

sibutramine and 8-hydroxy-2-(di-n-propylamino)tetralin

sibutramine has been researched along with 8-hydroxy-2-(di-n-propylamino)tetralin in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Auerbach, SB; Gundlah, C; Heal, DJ; Martin, KF1

Other Studies

1 other study(ies) available for sibutramine and 8-hydroxy-2-(di-n-propylamino)tetralin

ArticleYear
In vivo criteria to differentiate monoamine reuptake inhibitors from releasing agents: sibutramine is a reuptake inhibitor.
    The Journal of pharmacology and experimental therapeutics, 1997, Volume: 283, Issue:2

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Cyclobutanes; Fenfluramine; Fluoxetine; Male; Microdialysis; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin

1997